XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Equity (Tables)
9 Months Ended
Sep. 30, 2024
Schedule of outstanding, reserved and authorized shares under share-based compensation plans

September 30, 

December 31, 

(in thousands)

    

2024

    

2023

Outstanding options and restricted stock units

 

3,425

 

3,430

Reserved but unissued shares under the Plan

1,776

2,302

Total authorized shares under the Plan

 

5,201

 

5,732

Schedule of stock option activity

September 30, 

2024

(in thousands, except per share data)

Options to Purchase Common Stock

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Outstanding at beginning of year

 

2,759

$

2.07

 

5.38

Granted

 

$

 

Exercised

 

$

 

Forfeited/Expired

 

(102)

$

0.88

 

Outstanding at end of period

 

2,657

$

2.11

 

4.83

Exercisable at end of period

 

1,947

$

1.75

 

4.40

Schedule of restricted stock unit activity

September 30, 

2024

(in thousands, except per share data)

Number of Shares

Weighted Average Grant Date Fair Value

Nonvested at beginning of period

 

671

$

1.05

Granted

 

420

$

1.00

Vested

 

(323)

$

1.08

Forfeited

$

Nonvested at end of period

 

768

$

1.01

Schedule of share-based compensation activity

September 30, 

(in thousands)

    

2024

Reserved but unissued shares at beginning of period

188

Increases in the number of authorized shares

115

Grants

(36)

Reserved but unissued shares at end of period

 

267

Schedule of initial carrying value

(in thousands)

Allocated Amount

Common Stock

$

2,391

Public Warrants

1,831

$

4,222

(in thousands)

Allocated Amount

Common Stock

$

865

Private Pre-Funded Warrants

1,214

Private Warrants

2,389

$

4,468

(in thousands)

Allocated Amount

Common Stock

$

1,447

Participation Right Pre-Funded Warrants

580

Participation Right Private Warrants

2,250

$

4,277

Schedule of public warrants and underwriter warrants

Stock price 

$

0.79

Expected volatility 

108.01%

Contractual/expected term (in years)

5.00

Risk-free interest rate 

4.64%

Expected dividend yield 

0%

Stock price 

$

0.79

Expected volatility 

108.01%

Contractual/expected term (in years)

5.00

Risk-free interest rate 

4.64%

Expected dividend yield 

0%

Stock price 

$

0.65

Expected volatility 

108.01%

Contractual/expected term (in years)

5.00

Risk-free interest rate 

4.25%

Expected dividend yield 

0%

Summary of warrants outstanding

Warrants 

Pre-Funded Warrants(1) 

(in thousands, except per share data)

Number

Wtd. Avg. Exercise Price 

Wtd. Avg. Remaining Life (in years) 

Number

Wtd. Avg. Exercise Price 

Beginning Balance 

Granted

21,319

$

1.0535

4.99

4,499

$

0.0001

Exercised 

Forfeited/Expired 

Outstanding at Period End 

21,319

$

1.0535

4.99

4,499

$

0.0001

(1) Pre-Funded warrants have no expiration date and only expire when exercised in full. 

Restricted Stock Units (RSUs) [Member]  
Schedule of compensation expense

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

(in thousands, except per share data)

2024

2023

2024

    

2023

Compensation Expense

$

27

$

15

$

369

$

225

Weighted Average Value Per Share

$

0.93

$

0.80

$

1.29

$

0.80

Equity Incentive Plan  
Schedule of compensation expense

For the Nine Months Ended

September 30, 

(in thousands, except per share data)

    

2024

    

2023

Fair value

$

326

$

234

Weighted Average Value Per Share

$

1.06

$

0.79

Consultant Stock Plan  
Schedule of compensation expense

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

(in thousands, except per share data)

2024

    

2023

    

2024

    

2023

Compensation Expense

$

20

$

2

$

26

$

7

Weighted Average Value Per Share

$

0.72

$

0.66

$

0.74

$

0.66